As polynucleotide therapies have become more widely adopted in regenerative aesthetic practice, practitioners are increasingly seeking clarity not only on product selection, but on practical aspects of treatment delivery. One question that arises consistently during training and peer discussion is whether polynucleotides should be administered using a needle or a cannula. 

This is often framed as a binary choice. In reality, the answer is rarely that simple. In my experience teaching polynucleotide techniques, the question itself is valid, but the expectation of a universal answer is not. Delivery method cannot be separated from anatomical region, tissue composition and clinical indication, and applying a single approach across all areas risks oversimplifying a complex interaction between technique and outcome. 

Rather than advocating for one tool over the other, this article aims to explore how needle and cannula delivery each offer specific advantages and limitations, and why a considered, anatomy-led approach is more clinically appropriate than a uniform technique. 

Biological considerations and delivery depth  

When the question of needle vs. cannula arises, it is usually followed closely by a second: does the choice of delivery tool actually affect outcome? To answer that meaningfully, it is necessary to consider where polynucleotides are intended to act. 

The regenerative effects of polynucleotides are largely mediated within the dermis, where fibroblasts play a central role in extracellular matrix turnover, collagen synthesis and tissue repair.1 

This biological rationale underpins much of the published guidance describing intradermal delivery for polynucleotide treatments.2,3 Intradermal micro-bolus injection allows relatively precise placement within this compartment, facilitating interaction with fibroblast-rich tissue while limiting dispersion into deeper planes.2,3 

Cannula delivery, by contrast, offers less precision in terms of depth control. Even when introduced with the intention of superficial placement, cannulae are more commonly positioned in the subdermal plane rather than within the dermis itself, reflecting both their blunt tip design and the resistance encountered at the dermal-subdermal junction.4-6 

In anatomical regions where subcutaneous fat is well developed, this may result in partial deposition of product within adipose tissue rather than the dermis. 

The clinical significance of this remains incompletely defined, and available literature does not demonstrate clear inferiority of one approach over the other. From a mechanistic perspective, subdermal deposition may reduce the proportion of administered product available within the fibroblast-rich dermal compartment, potentially altering the biological exposure achieved compared with targeted intradermal delivery. 4,7  

This distinction is frequently discussed anecdotally, not as a prescriptive rule, but as one factor to be weighed alongside anatomical region, vascularity and clinical indication. 

Downtime, bruising and practical treatment considerations  

Discussion around delivery technique frequently extends beyond biological targeting to include downtime and visible post-treatment effects. While polynucleotides are associated with a favourable safety profile and a low incidence of significant complications, transient bruising remains the most commonly encountered adverse effect in routine practice.2 

Intradermal needle techniques require multiple skin punctures, each representing a discrete opportunity for vascular disruption. Although the absolute risk associated with any single puncture is low, cumulative punctures increase the likelihood of visible bruising. In addition, intradermal micro-bolus placement is typically associated with transient bleb formation, reflecting superficial dermal deposition of product. These blebs resolve spontaneously but may be noticeable in the early post-treatment period, particularly within the first 24 hours.4,8 

Cannula-based delivery alters this risk profile. By requiring a single entry point, cannula techniques reduce the number of skin penetrations and may therefore lessen the likelihood of puncture-related bruising.5,6 

While cannula use does not eliminate bruising risk entirely – particularly if traction is applied to a vessel – it is commonly associated with fewer and less conspicuous early post-treatment signs when compared with multiple needle entry techniques.5-9 

In my experience, these practical considerations are often as influential in technique selection as theoretical differences in depth or distribution. Patient expectations, social visibility of the treated area, and tolerance for short-term downtime all play a role in determining whether a needle or cannula approach is more appropriate in a given context. 

The periocular region 

The periocular region is often where the limitations of a uniform approach become most apparent. Anatomically, this area differs substantially from much of the face and presents a unique combination of structural, vascular and social considerations. 

Dermal thickness in the infraorbital region averages approximately 0.4-0.6 mm, compared with 2.5-3.0 mm in the lateral cheek.10 This reduced dermal depth limits the margin for error when attempting precise intradermal placement and increases the likelihood of vascular interaction. The region is also highly vascular, further elevating the risk of bruising when multiple punctures are performed.11 

In addition, the subcutaneous fat layer beneath the tear trough is minimal or absent, particularly in lighter skin phenotypes.12 This anatomical feature contributes to the characteristic blue-pink hue observed clinically, reflecting the visibility of the underlying orbicularis oculi muscle and its vascular supply. The limited subcutaneous fat in this area means that subdermal delivery is less likely to result in significant product loss. 

Taken together, these factors often shift the balance towards cannula-based delivery in the periocular region. While cannula placement may be less precise in terms of dermal targeting, the relative lack of subcutaneous fat reduces the potential impact of subdermal dispersion. Conversely, the use of multiple intradermal needle injections in this region increases the risk of bruising, with greater social and psychological impact than bruising in less conspicuous facial areas. 

In practice, these considerations frequently resonate with practitioners as they highlight how anatomical context should guide technique selection. The periocular region therefore serves as a clear example of why the question of needle versus cannula cannot be answered in absolute terms. 

Mid and lower face  

Beyond the periocular region, the anatomical considerations that influence delivery technique change appreciably. Across the mid-face and lower face, the dermis is thicker, vascular density is reduced, and the subcutaneous fat compartment is more developed.6 These factors alter both the risk profile and the practical implications of needle versus cannula delivery. 

In these regions, the likelihood of bruising associated with intradermal needle placement is generally lower than in the periocular area. At the same time, the presence of a more substantial fat compartment increases the chance that subdermal cannula placement may result in a proportion of product being deposited outside the dermis.  

From a mechanistic perspective, this may reduce the proportion of administered polynucleotide available to interact directly with fibroblast-rich tissue. 

For this reason, I often find that needle-based intradermal delivery is more easily justified across much of the mid-face and lower face. This approach allows more consistent dermal targeting while maintaining an acceptable downtime profile in areas where transient bruising is less socially conspicuous. 

This does not suggest that cannula use is inappropriate in these regions, but rather that the relative advantages of dermal precision become more relevant once vascular risk and dermal thickness are less limiting factors. 

Indication-led technique selection  

While regional anatomy provides a useful framework, clinical indication remains an equally important determinant of delivery technique. This becomes particularly apparent when treating perioral rhytides and atrophic scarring. 

Perioral lines are multifactorial in origin, reflecting dermal thinning, collagen loss, fat atrophy, dehydration and repeated muscular movement.13 As a result, they rarely respond optimally to a single intervention and often require a multimodal approach incorporating neuromodulators, fillers, energy-based devices and regenerative injectables. 

From a delivery perspective, cannula-based techniques may offer an additional mechanical benefit in this region. Perioral lines frequently correspond to fibrous attachments between skin and underlying muscle. Traversing these planes with a cannula can produce a mild subcision effect, partially releasing tethering structures while simultaneously delivering a regenerative stimulus.13,14 In this context, the choice of cannula is driven less by depth of delivery and more by the mechanical interaction with tissue. 

A similar rationale applies to the management of atrophic acne scarring, where fibrotic strands tether the dermis to deeper structures.14 In such cases, the delivery tool contributes directly to treatment effect, and cannula use may be advantageous regardless of the theoretical benefits of intradermal placement. 

These examples illustrate why delivery technique should be selected not only on anatomical grounds, but also in response to the specific structural characteristics of the condition being treated. 

Evidence base, limitations and clinical interpretation  

Despite the growing use of polynucleotides in regenerative aesthetic practice, there remains limited published evidence directly comparing delivery techniques. The majority of available literature focuses on product composition, biological mechanism and overall clinical safety, rather than on comparative evaluation of needle versus cannula administration.3,7,15 

Within training environments and professional discussion, unpublished observations are sometimes referenced. These have been reported to show no statistically significant difference in global outcomes between delivery methods. However, in the absence of peer-reviewed publication, such findings should be interpreted cautiously and cannot be used to support definitive technical recommendations. 

This limitation in the evidence base reinforces the importance of clinical reasoning grounded in anatomy and indication, rather than reliance on protocolised technique. Where robust comparative data are lacking, in my opinion, practitioners must draw on established anatomical knowledge, mechanistic plausibility and cumulative clinical experience when selecting a delivery approach. 

Importantly, the absence of clear evidence favouring one technique over another should not be interpreted as equivalence in all contexts. Rather, it highlights that outcome is likely influenced by a combination of factors, including tissue characteristics, vascularity, treatment area and patient-specific priorities, with delivery method representing one variable within a broader clinical decision-making process. 

Making a decision  

The question of whether to use a needle or a cannula when delivering polynucleotides will likely be a continued point of discussion. Both techniques are widely used, both are supported by clinical experience, and both can achieve effective outcomes when applied appropriately. The difficulty lies not in choosing between them, but in assuming that one approach can be applied uniformly across all anatomical regions and indications. 

As explored in this article, delivery technique should be viewed as context-dependent, informed by regional anatomy, tissue composition, vascularity and the specific structural characteristics of the concern being treated. In some areas, dermal precision may reasonably take precedence; in others, minimising bruising or leveraging a mechanical effect may be more clinically relevant. 

In the absence of definitive comparative evidence, an anatomy- and indication-led approach provides a practical and defensible framework for decision-making. Rather than seeking a single correct answer, clinicians are better served by understanding why one tool may be more appropriate than another in a given situation, and by adapting technique accordingly as experience develops.